Target-ABC (Targetted AntiBiotics for COPD): Can targetted antibiotic treatment improve the prognosis of COPD patients infected with Pseudomonas aeruginosa? - an "open label" randomized multicenter study.

Trial Profile

Target-ABC (Targetted AntiBiotics for COPD): Can targetted antibiotic treatment improve the prognosis of COPD patients infected with Pseudomonas aeruginosa? - an "open label" randomized multicenter study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Ciprofloxacin (Primary) ; Piperacillin/tazobactam (Primary)
  • Indications Chronic obstructive pulmonary disease; Pseudomonal infections; Respiratory tract infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top